跳至主要内容
临床试验/CTIS2022-502986-92-00
CTIS2022-502986-92-00招募中1 期

Anticoagulant therapy in patients with atrial fibrillation after surgical closure of the left atrial appendage: a randomized non-inferiority trial (The ATLAAC trial)

Odense University Hospital0 个研究点目标入组 1,220 人开始时间: 2023年4月25日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
1,220

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • Age > 18 years, Previously undergone any type of cardiac surgical procedure including any type of surgical left atrial appendage closure (use of any of the following techniques; amputation and suture closure, stapler closure, non-amputating suture closure or closure with an approved surgical occlusion device (e.g. AtriClip)) according to the National Patient Register (NPR) or the Western Danish Heart Registry (WDHR) from January 1st 2010 till April 1st 2023, Documented history of paroxysmal, persistent, or permanent atrial fibrillation or atrial flutter according to the electronic patient record, Informed consent

排除标准

  • Not receiving oral anticoagulant therapy (warfarin/DOAC), Patient specific conditions requiring OAC (e.g. mechanical valve, previous pulmonary embolism), Renal impairment (estimated glomerular filtration rate < 30), Allergy to contrast media, Pregnancy or breastfeeding

研究者

相似试验